(R)-4-((S)-1-Fluoroethyl)-3-(2-fluoropyrimidin-4-yl)oxazolidin-2-one, 97%, 100mg

Éthylène glycol, min 98 %, tech., 2,5 l, emballage plastique.

7-isopropoxy-2-oxo-2H-chromene-3-carboxylic acid, 95.0%, 1g

2-METHYL-2-(4-METHYLPIPERAZIN-1-YL)PROPANENITRILE, 97.0%, 1g

(3R,4R)-3-Fluorotetrahydro-2H-pyran-4-amine hydrochloride, 98%, 250mg

8-Pentadecanamine>96.0%(GC)(T)5mL

Ethyl 2-((4-Chloropyridin-2-yl)amino)-2-oxoacetate (Edoxaban Impurity), 98%, 50mg

5-Bromo-4-chloro-3-iodo-1H-pyrrolo[2,3-b]pyridine, 95.0%, 250mg

(4-methyl-2-phenyl-1,3-thiazol-5-yl)acetic acid, 95.0%, 250mg

2-Bromo-4-methylthiazole, 98.0%, 100mg

1,2-Ethanedisulfonic Acid Dihydrate>95.0%(T)5g

4,5-Dimethoxy-2-(trimethylsilyl)phenyl Trifluoromethanesulfonate>90.0%(GC)1g

6-(Acetyloxy)-2-naphthoic acid, 97.0%, 5g